People’s Daily Health Client reporter Kong Tianjiao
Beijing Medical Insurance Bureau recently announced Beijing’s third batch of non-national medical insurance drug catalogues. 141 varieties of non-national medical insurance drug catalogues such as cefonicil injection will be deleted from Beijing medical insurance drug catalogue, and “halometasone ointment” will be adjusted to “halometasone cream”, which will be implemented from December 31 this year.
On July 19, Kang Zhen, a professor at the School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, told the People’s Daily Health Client reporter: “The drugs you want to keep must be classic. Non-classic, alternative call out.”
A community health service center in Beijing, staff are dispensing medicines for patients. Photo by Xinhua News Agency reporter Peng Ziyang
Among the 141 kinds of medicines, 70 western medicines and 71 Chinese patent medicines
Among the 141 medicines to be called out, 70 Western medicines and 71 Chinese patent medicines. Western medicines include amlodipine for the treatment of hypertension, antibiotic drug clarithromycin, antiviral drug vidarabine, analgesic drug ibuprofen, etc.; Chinese patent medicines include Xiaoerganning syrup, Chaihuang Qingre Granules, Ganmao Qingre Oral Liquid, Qingkailing Oral Liquid, etc.
People’s Daily Health Client reporter found that in Western medicine, it is mainly the individual dosage forms of the medicines, not the whole medicines, not the whole medicines. For example, amlodipine, a commonly used drug for hypertension, is called “pill”; clarithromycin is called “dry suspension”; and the commonly used analgesic drug ibuprofen is called “gel”.
The Beijing Municipal Medical Insurance Bureau requires that the varieties that are included in the filing management in accordance with the previous relevant provisions of the city’s medical insurance drug catalog and do not belong to the national medical insurance drug catalog are transferred out of the city’s medical insurance drug reimbursement scope; each medical insurance is required to handle Institutions and designated medical institutions should update the medical insurance information system in a timely manner, and do a good job in the review and settlement of medical expenses for insured personnel; each designated medical institution should adjust its catalog of commonly used drugs in a timely manner to ensure that the above adjustments do not affect clinical medication.
According to clinical considerations, classic medicines are still reserved
“The western medicine amlodipine, which was transferred from Beijing Medical Insurance this time, is a very important type of medicines emphasized in the guidelines for hypertension. The effect is very good, it is a classic drug for high blood pressure. And this time it is just a pill, just a dosage form, it will not affect the daily use of patients.” Kang Zhen explained that the ibuprofen is not the usual oral medicine. The drug ibuprofen, but the external gel, has little effect. Even if the analgesic topical gel drug ibuprofen is transferred out, there are still better alternatives.
The transfer of medical insurance drugs is related to the clinical use. If there are alternatives now, the clinical choice will definitely be better. Kang Zhen gave an example, “For example, clarithromycin dry suspension has a better dry suspension, and if the treatment of the existing indications is not very targeted, its existence is not very meaningful. What you keep must be classic and practical. For example, the Chinese patent medicine Ganmao Qingre oral liquid and Qingkailing oral liquid in the catalogue are classics, but the oral liquid is inconvenient to carry, and now there are many granules and capsules for cold and heat The production cost of oral liquid is relatively higher than that of granules.”
It is reported that the “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2021)” contains Western and Chinese medicines. There are 2860 kinds of patent medicines, including 1486 kinds of western medicines and 1374 kinds of Chinese patent medicines. In addition, there are 892 kinds of Chinese herbal medicines that the fund can pay for. The National Medical Insurance Administration requires that all localities must strictly implement the drug catalog, and must not adjust the limited payment scope and A and B classifications of the drugs in the catalog. It is necessary to adjust the information system in a timely manner, update and improve the database, and include the drugs transferred in this adjustment into the fund payment scope according to regulations, and the transferred drugs should be transferred out of the fund payment scope at the same time.
Before, Beijing has completed the digestion of two batches of supplementary medicines for medical insurance. 61).